170 filings
8-K
HGENQ
Humanigen, Inc
8 Jan 24
Entry into a Material Definitive Agreement
5:02pm
8-K
HGENQ
Humanigen, Inc
14 Sep 23
Departure of Directors or Certain Officers
4:01pm
8-K
HGENQ
Humanigen, Inc
24 Jul 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:25pm
8-K
HGENQ
Humanigen, Inc
19 Apr 23
Other Events
6:00am
8-K
HGENQ
Humanigen, Inc
6 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:45pm
8-K
drt xvker
13 Mar 23
Regulation FD Disclosure
6:00am
8-K
4qq0 xqgls0
2 Mar 23
Other Events
5:15pm
8-K
n08r3 k2gm3r
24 Feb 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:48pm
8-K
rqipsg9d 1i1m3y3z
22 Dec 22
Entry into a Material Definitive Agreement
5:20pm
8-K
lqf1z7wu5i3
14 Nov 22
Humanigen Reports Third Quarter 2022 Financial Results
4:16pm
8-K
882 5y3eduj7h
6 Oct 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:13pm
8-K
1ne7pc5e
29 Sep 22
Departure of Directors or Certain Officers
5:15pm
8-K
h3zz0
2 Sep 22
Departure of Directors or Certain Officers
4:07pm
8-K
cpn1y
26 Aug 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
xufewas7gqhzro tf
12 Aug 22
Humanigen Reports Second Quarter 2022 Financial Results
4:07pm
8-K
6cf43n lr1l5z
26 Jul 22
Humanigen Implements Strategic Realignment of Pipeline and Resources to Achieve Key Clinical Milestones
4:05pm
8-K
r3b9kgddd1nn
13 Jul 22
Humanigen receives preliminary topline data from NIH/NIAID study of lenzilumab in ACTIV-5/BET-B
6:01am
8-K
o8ne8b v31
30 Jun 22
Other Events
8:24am
8-K
gbv9nt nom3
10 Jun 22
Submission of Matters to a Vote of Security Holders
4:56pm
8-K
6wj1c q30r
5 May 22
Humanigen Reports First Quarter 2022 Financial Results
4:05pm